Prognostic value of absolute lymphocyte count in patients with advanced esophageal cancer treated with immunotherapy: a retrospective analysis

BACKGROUND: Immunotherapy has become the standard of treatment for recurrent metastatic esophageal cancer (EC), and the value of efficacy predictive markers represented by programmed death-ligand 1 (PD-L1) is limited. The purpose of this study is to analyze the prognostic value of peripheral blood a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Qi, Bi, Yanping, Xue, Jiao, Liu, Yandong, Zhu, Jiaxing, Qin, Songbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358517/
https://www.ncbi.nlm.nih.gov/pubmed/35957729
http://dx.doi.org/10.21037/atm-22-2669

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358517/
https://www.ncbi.nlm.nih.gov/pubmed/35957729
http://dx.doi.org/10.21037/atm-22-2669

Ejemplares similares